Aura Biosciences, Inc.
Aura Biosciences, Inc.
Your view on AURA
Overview
What the company does, where it operates, and who runs it.
About Aura Biosciences, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Elisabet de los Pinos
- Headquarters
- 85 Bolton Street, Boston, MA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Elisabet de los Pinos
- Headquarters
- 85 Bolton Street, Boston, MA, US
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.